Avid Bioservices Receives Six 2018 CMO Leadership Awards
March 22 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality development and
manufacturing services to biotechnology and pharmaceutical
companies, today announced that the company has been named a
recipient of six 2018 Contract Manufacturing Organization (CMO)
Leadership Awards. Presented by the industry publication Life
Science Leader and based on market research and surveys conducted
by Industry Standard Research (ISR), these awards are intended to
honor those companies in the contract manufacturing space that
provide their customers with the industry’s highest level of
service. Now in its 7th year, Life Science Leader’s CMO
Leadership Awards aim to provide industry insiders with accurate
and reliable customer feedback to assist them in choosing a
reputable partner for their development and manufacturing needs.
Avid received awards in the following
categories:
- Quality
- Reliability
- Capabilities
- Expertise
- Compatibility
- Service
“We believe that one of the greatest competitive
differentiators helping to drive the growth of Avid’s CDMO business
is the company’s long-standing reputation for excellence within the
industry. With the CMO Leadership Award winners selected, in
part, based on surveys of customers of CDMO services, our receipt
of six awards highlights the meaningful impact our focus on
quality, reliability, capabilities, expertise, compatibility and
service is having on industry sentiment,” said Roger Lias, Ph.D.,
president and chief executive officer of Avid Bioservices. “We’d
like to take this opportunity to thank all of our employees who
strive for excellence every day, as well as those individuals who
championed Avid as being worthy of each of the CMO awards we
received.”
For more information about Life Science Leader’s
CMO Leadership Awards, please visit:
http://cmoleadershipawards.com/.
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract development
and manufacturing organization (CDMO) focused on development and
cGMP manufacturing of biopharmaceutical products derived from
mammalian cell culture. The company provides a comprehensive
range of process development, high quality cGMP clinical and
commercial manufacturing services for the biotechnology and
biopharmaceutical industries. With nearly 25 years of
experience producing monoclonal antibodies and recombinant proteins
in batch, fed-batch and perfusion modes, Avid's services include
cGMP clinical and commercial product manufacturing, purification,
bulk packaging, stability testing and regulatory strategy,
submission and support. The company also provides a variety
of process development activities, including cell line development
and optimization, cell culture and feed optimization, analytical
methods development and product characterization.
www.avidbio.com
Contacts:
Kelly Pisarev Lord
Avid Bioservices, Inc.
(800) 987-8256
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2023 to Apr 2024